Structure The TMEM89 gene is found on the minus strand of
chromosome 3 (3p21.31) from 48,658,192 to 48,659,288 and is 1,011
nucleotides long. The gene has two
exons. Expression of the TMEM89 gene has also been found in low amounts in the brain tissue from a mouse cerebellum.
Gene expression neighborhood Human TMEM89 is a part of the Human Protein Atlas expression cluster 23:
SpermatidS -
Flagellum &
Golgi organization. The 15 closest expression neighbors include
OR4M1, ANTXRL, TGIF2LX, CPXCR1, C3orf84,
CXorf66,
CLDN17, C11orf94, USP50, SPDYE4,
MMP20,
SSMEM1,
SPMAP1, SPACA1, and LYZL1. TMEM89 expression is higher in cells that have macrophage migration inhibitory factor (MIF) knocked down compared to the control. TMEM89 expression is the lowest in cardiomyocytes from human embryonic stem cells, compared to expression in human embryonic stem cells, embryoid bodies with beating cardiomyocytes, and cardiomyocytes from fetal hearts.
Clinical significance Gene expression of TMEM89 was found to be upregulated in upper tract urothelial carcinomas, and therefore predicted as a possible biomarker secretory protein for these types of carcinomas. The TMEM89 gene was found to be a potential modifier of autism spectrum disorder severity in a SNP analysis. Gene expression of TMEM89 was also used in a model that predicted the risk score for a potential relapse in stage 1 testicular germ cell tumors. == Protein ==